FDA
-
-
-
-
-
-
-
Canopy Growth Reports First Quarter Fiscal 2026 Financial Results; Cannabis Revenue Increased 24% Year-Over-Year
-
-
-
-
-
-
-
Cannabis stocks rally after DOJ proposal to reclassify marijuana
-
-
-
-
-
-
-
Canopy Growth Reports Third Quarter Fiscal Year 2023 Financial Results and Announces Canadian Business Transformation Plan
-
-
-
-
-
-
-
Canopy Growth Reports Second Quarter Fiscal 2022 Financial Results
-
-
-
-
-
-
-
Pre-Open 02/14: (BTAI) (CGC) (IMGN) Higher (PLSE) (SLGL) (LPSN) Lower (more...)
-
-
-
-
-
-
-
Canopy Growth (CGC) Announces Acquisition of KeyLeaf Life Sciences
-
-
-
-
-
-
-
Spectrum Therapeutics provides update on its global clinical research program and unveils pharmacovigilance program
-
329,989 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

